Models useful for estimating cost effectiveness of new RA treatments

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.390, 2002-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost effectiveness of celecoxib, rofecoxib in OA and RA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cost effectiveness of celecoxib, rofecoxib in OA and RA

By  

Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Estimating `Costs' for Cost-Effectiveness Analysis

By Miners Alec  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 745-751

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of stroke treatments and secondary preventions

By Pan Feng   Hernandez Luis   Ward Alex  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1751-1760

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of different postoperative analgesic treatments

By Engoren Milo  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1507-1519

Informa Healthcare

Access to resources Recommend Favorite